Es Ghc Bg Monitoring

---
name: es-ghc-bg-monitoring
description: This skill ensures ongoing blood glucose monitoring with adjustment of insulin dosing to manage glucocorticoid-associated hyperglycemia and prevent hypoglycemia during taper or discontinuation. It is triggered when clinicians ask, "Do we need to adjust insulin doses as glucocorticoids change?"
---

# Implement ongoing blood glucose monitoring and insulin dose adjustment

## STEP 1 — Gather Information
Collect current glucocorticoid type, dose, and schedule; recent point-of-care blood glucose (POC-BG) values (fasting, pre-meal, random, and bedtime); existing insulin regimen (type, dose, timing); renal function; hypoglycemia risk factors (age, BMI, total daily insulin dose, CKD, history of hypoglycemia); and nutritional status.

## STEP 2 — Rule In / Rule Out
Determine if glucocorticoid dose is being changed (tapered, held, or increased) versus stable. If glucocorticoid dose is changing, proceed to adjust insulin; if dose is stable, maintain current insulin regimen and continue routine monitoring.

## STEP 3 — Classify or Stratify
Stratify glucocorticoid change magnitude: low (≤25% dose change), moderate (25‑50%), or high (>50%). Also classify insulin regimen as NPH‑based or basal‑bolus (BBI) to guide adjustment magnitude.

## STEP 4 — Decide
For NPH‑based regimens, adjust the total daily NPH dose by approximately 10‑20% per 25% glucocorticoid change (increase for rising GC, decrease for taper); for BBI, adjust basal and prandial components proportionally. Set monitoring frequency to POC‑BG every 4‑6 hours (or more often if hypoglycemia suspected) and reassess after each glucocorticoid dose change.

## Clinical Guardrails / Mimics / Pitfalls
Avoid making insulin adjustments based on a single BG value; never use sliding‑scale insulin alone for GC‑associated hyperglycemia; do not discontinue insulin abruptly during glucocorticoid taper; safeguard against hypoglycemia by checking for risk factors and holding or reducing insulin if BG <70 mg/dL; confirm CGM trends with POC‑BG before dosing changes.

## Concrete Clinical Example
A patient on prednisone 40 mg daily develops hyperglycemia (BG 180‑250 mg/dL) and is started on NPH 10 U each morning. When prednisone is tapered to 20 mg daily, the NPH dose is reduced to 8 U each morning. POC‑BG is checked q6h; if BG falls below 70 mg/dL, the NPH dose is held and reassessed.

**Source:** Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, DOI: 10.1210/clinem/dgac278